NIDIA ORTEGA: Open Payments
NPI 1013392935 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 64 payments from 15 companies in 2025. Trend: 2023 $1,212 · 2024 $1,273 · 2025 $1,349
Food & beverage: $1,349
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $372 |
| ABBVIE INC. | 19 | $273 |
| Novo Nordisk Inc | 10 | $166 |
| Amgen Inc. | 9 | $156 |
| Lilly USA, LLC | 4 | $72 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Corcept Therapeutics | 3 | $59 |
| Exact Sciences Corporation | 2 | $50 |
| Dexcom, Inc. | 2 | $43 |
| Mannkind Corporation | 1 | $17 |
Products named: JARDIANCE, LINZESS, Ozempic, OTEZLA, VRAYLAR, Korlym, EVENITY, Cologuard Collection Kit.
Industry payments across NJ — which companies pay providers there.
